Study Stopped
Converted from a pilot into a larger study which we will enter as a new protocol
Pilot Study of Intervention to Reduce Sunburns in Melanoma Survivors
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
This project will pilot test whether a wearable device that tracks sun exposure and provides alerts regarding sun exposure and protection behaviors will reduce sunburns in melanoma survivors. The use of wearable technology devices has grown quickly over the last decade and studies using these devices to promote physical activity and weight loss have been promising. The investigators will pilot test the technology device versus a similar control device in 80 melanoma survivors and compare sunburns between the two groups after the three month intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2018
CompletedFirst Posted
Study publicly available on registry
May 8, 2018
CompletedStudy Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedApril 17, 2019
April 1, 2019
7 months
April 25, 2018
April 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sunburn
Self-report of a sunburn during study period
3 months
Study Arms (2)
Intervention
EXPERIMENTALMicrosoft Band 2 application with UV messaging activated
Control
ACTIVE COMPARATORMicrosoft Band 2 application (UV messaging not active)
Interventions
wearable device (wrist) and associated mobile application; UV sensor and messaging activated
wearable device (wrist) and associated mobile application; UV messaging not activated
Eligibility Criteria
You may qualify if:
- years old
- Diagnosed with stage I-III cutaneous invasive melanoma between 2009 and 2017 and treated at the University of Minnesota
- Able to read/write in English
- Own a smartphone
- Able to provide voluntary informed consent
You may not qualify if:
- Patients currently undergoing adjuvant therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Minnesotalead
- Melanoma Research Alliancecollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2018
First Posted
May 8, 2018
Study Start
February 1, 2020
Primary Completion
September 1, 2020
Study Completion
May 1, 2021
Last Updated
April 17, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share